DK0922226T3 - Fremgangsmåde til registrering af en organismes status ved måling af peptider - Google Patents

Fremgangsmåde til registrering af en organismes status ved måling af peptider

Info

Publication number
DK0922226T3
DK0922226T3 DK97918977T DK97918977T DK0922226T3 DK 0922226 T3 DK0922226 T3 DK 0922226T3 DK 97918977 T DK97918977 T DK 97918977T DK 97918977 T DK97918977 T DK 97918977T DK 0922226 T3 DK0922226 T3 DK 0922226T3
Authority
DK
Denmark
Prior art keywords
organism
status
recording
peptides
measuring peptides
Prior art date
Application number
DK97918977T
Other languages
Danish (da)
English (en)
Inventor
Michael Schrader
Hans-Georg Opitz
Wolf-Georg Forssmann
Peter Schulz-Knappe
Original Assignee
Biovision Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26028345&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0922226(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1996132521 external-priority patent/DE19632521A1/de
Application filed by Biovision Ag filed Critical Biovision Ag
Application granted granted Critical
Publication of DK0922226T3 publication Critical patent/DK0922226T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK97918977T 1996-08-13 1997-08-13 Fremgangsmåde til registrering af en organismes status ved måling af peptider DK0922226T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1996132521 DE19632521A1 (de) 1996-08-13 1996-08-13 Verfahren zur Gewinnung von Peptiden aus Köperflüssigkeiten und Geweben sowie Zellüberständen und zur Identifikation von krankheitsrelevanten Peptidmarkern
DE19725362 1997-06-16
PCT/EP1997/004396 WO1998007036A1 (de) 1996-08-13 1997-08-13 Verfahren zur erfassung des status eines organismus durch messung von peptiden

Publications (1)

Publication Number Publication Date
DK0922226T3 true DK0922226T3 (da) 2003-07-07

Family

ID=26028345

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97918977T DK0922226T3 (da) 1996-08-13 1997-08-13 Fremgangsmåde til registrering af en organismes status ved måling af peptider

Country Status (16)

Country Link
US (1) US6875616B1 (ru)
EP (1) EP0922226B2 (ru)
JP (1) JP2001508864A (ru)
CN (1) CN1233326A (ru)
AT (1) ATE234469T1 (ru)
AU (1) AU720626B2 (ru)
CA (1) CA2263443C (ru)
CZ (1) CZ294729B6 (ru)
DE (1) DE59709517D1 (ru)
DK (1) DK0922226T3 (ru)
EA (1) EA001033B1 (ru)
ES (1) ES2191175T3 (ru)
IS (1) IS4971A (ru)
PL (1) PL186810B1 (ru)
PT (1) PT922226E (ru)
WO (1) WO1998007036A1 (ru)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936424B1 (en) 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer
DE10021737C2 (de) * 2000-05-04 2002-10-17 Hermann Haller Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird
US6693080B2 (en) 2001-04-30 2004-02-17 Syn X Pharma Biopolymer marker indicative of disease state having a molecular weight of 1521 daltons
US7015004B2 (en) * 2001-11-23 2006-03-21 Syn X Pharma, Inc. Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance
US6627606B2 (en) 2001-04-30 2003-09-30 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1465 daltons
US6627607B2 (en) 2001-04-30 2003-09-30 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons
US6756476B2 (en) 2001-04-30 2004-06-29 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons
US6617308B2 (en) 2001-04-30 2003-09-09 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons
US7087435B2 (en) 2001-04-30 2006-08-08 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons
US20040198950A1 (en) 2001-04-30 2004-10-07 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons
US6620787B2 (en) 2001-04-30 2003-09-16 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons
US20020160420A1 (en) * 2001-04-30 2002-10-31 George Jackowski Process for diagnosis of physiological conditions by characterization of proteomic materials
US6599877B2 (en) 2001-04-30 2003-07-29 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1020 daltons
US7294688B2 (en) 2001-04-30 2007-11-13 Nanogen Inc. Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons
US6602855B2 (en) 2001-04-30 2003-08-05 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
US6677303B2 (en) 2001-04-30 2004-01-13 Syn X Pharma Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons
US6890763B2 (en) 2001-04-30 2005-05-10 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons
US7008800B2 (en) 2001-04-30 2006-03-07 Artemis Proteomics, Ltd. Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons
US7314717B2 (en) 2001-04-30 2008-01-01 Nanogen Inc. Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons
US6703366B2 (en) 2001-04-30 2004-03-09 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons
US6593298B2 (en) 2001-04-30 2003-07-15 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons
US6620786B2 (en) 2001-04-30 2003-09-16 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having molecular weight of 2937 daltons
US20020160533A1 (en) 2001-04-30 2002-10-31 George Jackowski Biopolymer marker indicative of disease state having a molecular of weight of 1525 daltons
US6627608B2 (en) 2001-04-30 2003-09-30 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1206 daltons
DE10123711A1 (de) * 2001-05-15 2003-02-27 Wolfgang Altmeyer Verfahren zur Bestimmung der Herkunft biologischer Materialien
US7132244B2 (en) * 2001-11-21 2006-11-07 Syn X Pharma, Inc. Betaine/GABA transport protein biopolymer marker indicative of insulin resistance
US7314762B2 (en) 2001-11-21 2008-01-01 Nanogen, Inc. Apolipoprotein biopolymer markers indicative of insulin resistance
US7179610B2 (en) 2001-11-23 2007-02-20 Nanogen Inc. Complement C3 precursor biopolymer markers indicative of insulin resistance
US7074576B2 (en) 2001-11-23 2006-07-11 Syn X Pharma, Inc. Protein biopolymer markers indicative of alzheimer's disease
US7179606B2 (en) 2001-11-23 2007-02-20 Syn X Pharma, Inc. IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease
US7122327B2 (en) 2001-11-23 2006-10-17 Nanogen Inc. Biopolymer markers indicative of type II diabetes
US20030100014A1 (en) * 2001-11-23 2003-05-29 George Jackowski Apolipoprotein biopolymer markers predictive of type II diabetes
US7094549B2 (en) 2001-11-23 2006-08-22 Syn X Pharma, Inc. Fibronectin biopolymer marker indicative of insulin resistance
JP2005510716A (ja) * 2001-11-23 2005-04-21 シン．クス ファーマ、インコーポレイテッド インスリン耐性を示すグロビンバイオポリマーマーカー
US7097989B2 (en) 2001-11-23 2006-08-29 Syn X Pharma, Inc. Complement C3 precursor biopolymer markers predictive of type II diabetes
US7026129B2 (en) * 2001-11-23 2006-04-11 Syn X Pharma, Inc. IG lambda biopolymer markers predictive of Alzheimers disease
US7135297B2 (en) 2001-11-23 2006-11-14 Nanogen Inc. Protein biopolymer markers indicative of insulin resistance
US6890722B2 (en) 2001-11-23 2005-05-10 Syn X Pharma, Inc. HP biopolymer markers predictive of insulin resistance
US7052849B2 (en) 2001-11-23 2006-05-30 Syn X Pharma, Inc. Protein biopolymer markers predictive of insulin resistance
US7179605B2 (en) 2001-11-23 2007-02-20 Nanogen Inc. Fibronectin precursor biopolymer markers indicative of alzheimer's disease
US7125678B2 (en) 2001-11-23 2006-10-24 Nanogen, Inc. Protein biopolymer markers predictive of type II diabetes
JP2006522340A (ja) 2003-04-02 2006-09-28 メルク　エンド　カムパニー　インコーポレーテッド 質量分析データの分析法
DE10341193A1 (de) * 2003-09-06 2005-03-31 Mosaiques Diagnostics And Therapeutics Ag Vorrichtung und Verfahren zur quantitativen Auswertung der in einer Körperflüssigkeitsprobe enthaltenden Polypeptide sowie Marker zur Erkennung von pathologischen Zuständen
WO2006044666A2 (en) * 2004-10-15 2006-04-27 Northeastern University Detection of disease associated proteolysis by direct mass spectrometry analysis of low molecular weight peptides
WO2009016431A1 (en) * 2007-08-01 2009-02-05 Digilab, Inc. Sample preparation method and apparatus
EP2364447B1 (en) * 2008-10-31 2019-06-12 Biomerieux, Inc Method for the identification of microorganisms
MX2011004108A (es) * 2008-10-31 2011-08-15 Bio Merieux Inc Metodos para la separacion, caracterizacion y/o identificacion de microorganismos utilizando espectrometria de masas.
WO2010062349A1 (en) * 2008-10-31 2010-06-03 Biomerieux, Inc. Methods for separation and characterization of microorganisms using identifier agents
ES2821376T3 (es) 2012-03-30 2021-04-26 Bd Kiestra Bv Selección automática de microorganismos e identificación usando MALDI

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5537944A (en) * 1978-09-09 1980-03-17 Seiichi Shibata Diagnosis chemical and diagnosis method of kidney disease
EP0651816A4 (en) * 1992-07-15 1995-10-25 Univ South Florida LEVELS OF CCK PEPTIDES IN BLOOD IN RELATION TO THE TREATMENT OF PANIC EARTHS.
US5492834A (en) * 1993-07-09 1996-02-20 Beckman Instruments, Inc. Method of sample preparation for urine protein analysis with capillary electrophoresis
DE4427531A1 (de) * 1994-08-04 1996-02-08 Forssmann Wolf Georg Humanes zirkulierendes beta-Defensin hBD-1
JP3579549B2 (ja) * 1995-10-24 2004-10-20 株式会社トクヤマ 糖尿病または糖尿病合併症用マーカーとしての使用

Also Published As

Publication number Publication date
CZ49199A3 (cs) 2000-04-12
IS4971A (is) 1999-02-10
US6875616B1 (en) 2005-04-05
CN1233326A (zh) 1999-10-27
EP0922226B2 (de) 2008-06-25
PT922226E (pt) 2003-07-31
ATE234469T1 (de) 2003-03-15
CA2263443C (en) 2004-03-30
ES2191175T3 (es) 2003-09-01
WO1998007036A1 (de) 1998-02-19
CA2263443A1 (en) 1998-02-19
AU4298897A (en) 1998-03-06
PL186810B1 (pl) 2004-02-27
DE59709517D1 (de) 2003-04-17
EA199900196A1 (ru) 1999-06-24
PL331612A1 (en) 1999-08-02
CZ294729B6 (cs) 2005-03-16
EP0922226B1 (de) 2003-03-12
JP2001508864A (ja) 2001-07-03
EP0922226A1 (de) 1999-06-16
AU720626B2 (en) 2000-06-08
EA001033B1 (ru) 2000-08-28

Similar Documents

Publication Publication Date Title
DK0922226T3 (da) Fremgangsmåde til registrering af en organismes status ved måling af peptider
DK0901634T3 (da) System til bestemmelse af mindst en parameter i mindst en prøve af en fysiologisk væske samt en kassette
BR0006035A (pt) Mancal com dispositivo para detectar pulsos magnéticos de um codificador e o dispositivo compreendendo vários elementos sensores alinhados
DK1000345T3 (da) Fremgangsmåde og apparat til dannelse af referencer for fluorescensintensitetssignaler
DK0988534T3 (da) Elektroniske fremgangsmåder og apparat til detektering af analytter
DE69709921D1 (de) Optische detektionsvorrichtung für chemische analysen an kleinvolumigen proben
DE69912899D1 (de) Blutgerinnsel-Detektor
DK0820522T3 (da) Assays og indretninger til detektering af ekstrahepatisk galdeatresi
NO163658C (no) Testanordning for aa teste branndetekteringssystem med fiberoptikk.
DE60135839D1 (de) Nachweis von analyten
DE59813278D1 (de) Korrektur von blutdruckmessungen bei invasiven flüssigkeitsgefüllten systemen
NO20003709L (no) Fremgangsmate for detektering av en analytt, og omsluttingsmiddel og kit for anvendelse deri
DE69729306D1 (de) Ereignisfeststellung mit kurzen und langen Mittelwerten
ES2186121T3 (es) Mejora de los resultados de los dosificados de inmunodeteccion gracias al empleo de varios trazadores.
DE68914630D1 (de) System zum kalibrieren der ausgabeebene eines optischen korrelators.
DE69708786D1 (de) Vorrichtung zum Erfassen der Verschlechterung eines Luft-Kraftstoff-Verhältnis-Sensors
NO974000D0 (no) Fremgangsmåte og forbindelser for påvisning av analytter, ved hjelp av remanensmålinger, samt anvendelse av slike forbindelser
NO861441L (no) Anordning for maaling av permeabiliteter til faste proever.
DK259385A (da) Apparat til proevning, specielt trykproevning af beholdere
BR0015288A (pt) Método e aparelho para o teste de um sensor
DE59006602D1 (de) Sensorsystem.
DK0983497T3 (da) Apparat til titrering og cirkulering af gasser og cirkulering af et absorptionsmiddel eller et adsorptionsmiddel
DK0897283T3 (da) Analyse for tilstedeværelse af degenerativ hjernesygdom
DK60297A (da) Detektor til sporing af væskelækager
NO960783L (no) Fremgangsmåte og apparat for å hindre falsk respons i en optisk detektor